Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA binding motif protein 17 pseudogene 3 (RBM17P3) is a pseudogene related to the functional RNA binding motif protein 17 (RBM17), which encodes a spliceosomal component involved in mRNA splicing[1][6]. As a pseudogene, RBM17P3 does not encode a functional protein and is not known to have direct biological function or clinical significance. While some pseudogenes can regulate their parental gene through mechanisms such as competing for microRNAs or RNA-binding proteins, there is no specific evidence that RBM17P3 exerts such effects[3]. It is not considered a therapeutic target, a biomarker, or a disease-associated gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA binding motif protein 17 pseudogene 3 (RBM17P3).